Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DelotaSYDRF 18 EV-to-EBIT is 9.87 as of Jul. 27, 2026. GuruFocus rates SYDRF with a GF Score™ of 18/100 and a GF Value™ of $0.17. The stock has 4 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Delota ranks better than 74.31% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Delota's Enterprise Value is $4.12 Mil.
Delota's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $0.42 Mil. Therefore, Delota's EV-to-EBIT for today is 9.87.
The historical rank and industry rank for Delota's EV-to-EBIT or its related term are showing as below:
SYDRF'
s EV-to-EBIT Range Over the Past 10 Years
Min: -25.16 Med: -1.4 Max: 68.77
Current: 9.73
During the past 11 years, the highest EV-to-EBIT of Delota was 68.77. The lowest was -25.16. And the median was -1.40.
SYDRF's EV-to-EBIT is ranked better than 74.31% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.88
vs SYDRF: 9.73
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Delota's Enterprise Value for the quarter that ended in Dec. 2025 was $5.75 Mil.
Delota's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.42 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delota EV-to-EBIT Related Terms
Delota EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Delota's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Delota's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delota EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Delota's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Delota's EV-to-EBIT falls into.
Delota's current Enterprise Value is $4.12 Mil.
Delota's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.42 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delota (SYDRF) has a EV-to-EBIT of 9.87 as of Jul. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Delota and its competitors. According to the industry distribution chart, Delota ranks #121 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 25.7%.
Is Delota's EV-to-EBIT too high?
Delota's current EV-to-EBIT is 9.87. The Healthcare Providers & Services industry median EV-to-EBIT is 15.88. Delota's value of 9.87 is 37.8% below this industry median. Based on the distribution chart, Delota ranks #121 out of 471 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Delota has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Delota's EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Delota ranks #121 out of 471 companies for EV-to-EBIT. This puts Delota in the upper half of its industry. The industry median EV-to-EBIT is 15.88. Delota's value of 9.87 is 37.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.88, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delota's current EV-to-EBIT of 9.87 is 37.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Delota and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delota's current EV-to-EBIT is 9.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delota stock overvalued right now?
Delota (SYDRF) has a current EV-to-EBIT of 9.87. The stock's GF Value™ is $0.17, compared to a current price of $0.10 — trading 41.2% below its estimated fair value. The current EV-to-EBIT is 9.87 and 37.8% below the Healthcare Providers & Services industry median of 15.88. Delota's overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Delota (SYDRF), the current EV-to-EBIT is 9.87 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Delota (SYDRF) Overvalued in 2026?
Based on GuruFocus' analysis, Delota stock appears to be undervalued.
The current stock price of $0.10 is trading 41.2% below its estimated GF Value™ of $0.17.
Key valuation signals for SYDRF:
EV-to-EBIT: 9.87
GF Value™: $0.17 vs. price of $0.10 (41.2% below fair value)
Industry Position: 37.8% below the Healthcare Providers & Services median (#121 of 471)
No single metric tells the full story. See the SYDRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Delota Corp is a cannabis and nicotine retailer. The company is engaged in developing retail cannabis and nicotine brands in Canada by growing its retail footprint and developing retail banners. The Company's flagship brand, one hundred eighty Smoke Vape Store, stands as Ontario's omni channel specialty vape retailer, fueling innovation, growth, and leadership in the nicotine vape and alternative tobacco sector. The Company operates twenty nine brick-and-mortar specialty vape stores in Ontario under the one hundred eighty Smoke Vape Store brand, a dominant national e-commerce platform and three licensed dispensaries in Ontario under the Offside Cannabis brand.
18GF Score
Get the complete analysis for SYDRF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SYDRF has been successfully added to your 
